As a broader range of industries have joined the gig economy, multiple jurisdictions have confronted an essential question. Should workers in the gig economy be treated as employees, subject to expanded legal protections, or as independent contractors, responsible for a greater proportion of their own welfare? Some US states have adopted legal tests that require employers to treat most gig economy workers as employees, while others have specifically classified them as independent contractors. Meanwhile, many other countries—including an increasing number in the developing world—are beginning to confront the same question in political debates and legal proceedings. This panel will discuss the status of the issue in the United States and around the world. As other states and countries continue to debate new legislation, are they more likely to treat gig workers as employees or independent contractors? In the meantime, how do companies and workers manage their uncertain status, whether through specific changes in practice or through broad advocacy campaigns?
Rajiv Ahuja, associate director at the Milken Institute, focusing on the future of aging, moderates this Advances in Science webinar with featured guest Richard J. Hodes, M.D., Director of the National Institute on Aging (NIA) at the...
How are nonprofit organizations leveraging venture philanthropy to accelerate the development of treatments and cures? As part of The Research Acceleration and Innovation Network (TRAIN) webinar series, FasterCures takes a deeper dive into...
How are patient organizations taking on the challenge of diversity, equity, and inclusion within biomedical research to create better health outcomes for all patient populations, especially those historically excluded from research and...
While employment in much of the United States has recovered successfully from the fallout of the COVID-19 pandemic, California remains one of the few states that has struggled to recoup jobs at a pace on par with the rest of the nation...
In a webinar on September 23, 2020, FasterCures brought together Peter Marks, director of the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research, Gwen Nichols, chief medical officer of the Leukemia &...
For too long, the need for national infrastructure solutions has been limited to conversations of roads, bridges and stalemates in Congress. The COVID-19 pandemic has altered the financial circumstances of many communities just as high...
Data from and about patients is essential to advance biomedical research and development, but its collection and dissemination can be a significant investment of time and resources for patient organizations that choose to be the...
This webinar focused on the development and deployment of patient-centered outcome measures (PCOMs) for research and care, highlighting the importance of integrating patients’ voices into the research process. Unlike traditional patient...